4th Quarter - Report — F. HOFFMANN-LA ROCHE LTD, AND ITS AFFIL… for F HOFFMANN-LA ROCHE LTD AND ITS AFFILIA… (2009)

Firm

F. HOFFMANN-LA ROCHE LTD, AND ITS AFFILIATES

Client

F HOFFMANN-LA ROCHE LTD AND ITS AFFILIATES

Income

—

Expenses

$1,042,124

Expense method

A: Lobbying Disclosure Act definitions

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Advocate on legislative changes regarding biosimilars; pandemic preparedness, health reform, health care reform legislation, including safety and data exclusivity issues regarding follow-on biologics; policy analysis; address concerns regarding the federal government's purchase and stockpiling of Tamiflu; HR 3200 America's Affordable Health Choices Act: and the America's Healthy Future Act of 2009; H.R. 1 - Pandemic influenza funding; H.R. 1105 Omnibus Appropriations Act; Pandemic funding issues; FY10 Labor HHS Appropriations legislation: H.R. 2346 Supplemental Appropriations Act of 2009 Congress and Federal Agencies; community relations and outreach to develop and maintain relationships with minority groups and health organizations; Public policy such as developming strategies on the most effective approaches to tell the story of Roche's efforts to address and try to resolve health disparities affecting minority communities.

Lobbyist	Covered position, as disclosed
THOMAS BARNETT	Director, Roche Diagnostics
KATHLEEN A CLAESSENS	Director, Roche Diagnostics
DARIN GARDNER	Director, Federal Government Affairs
ANNA GRIFFIN	Director, Federal Government Affairs
KATHERINE MARTIN	Director, Federal Government Affairs
EVAN MORRIS	Vice President, Federal Government Affairs
BRUCE THOMAS TAYLOR	Director, Roche Diagnostics

Contacted: HOUSE OF REPRESENTATIVES; Executive Office of the President (EOP); Office of Personnel Management (OPM); Veterans Affairs, Dept of (VA); Health & Human Services, Dept of (HHS); SENATE

Bills named: H.R. 1 (111th), H.R. 3200 (111th), H.R. 1105 (111th), H.R. 2346 (111th)

Budget/Appropriations BUD

Issues related to government purchases of pandemic drugs, Tamiflu

Lobbyist	Covered position, as disclosed
DARIN GARDNER	Director, Federal Government Affairs

Contacted: Executive Office of the President (EOP); SENATE; Veterans Affairs, Dept of (VA); Office of Personnel Management (OPM); HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS)

Homeland Security HOM

Labor HHS Appropriations - S. 3230 and H.R. 3042, Homeland Security Appropriations S3181 and H.R. 6947 Congress and Federal Agencies

Lobbyist	Covered position, as disclosed
DARIN GARDNER	Director, Federal Government Affairs

Contacted: Veterans Affairs, Dept of (VA); Office of Personnel Management (OPM); Health & Human Services, Dept of (HHS); SENATE; HOUSE OF REPRESENTATIVES; Executive Office of the President (EOP)

Bills named: S. 3230 (111th), H.R. 6947 (111th), H.R. 3042 (111th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.